Oxford Nanopore (ONT.L)

Executive Summary

Oxford Nanopore Technologies is a pioneer in nanopore-based molecular sensing, enabling real-time, long-read sequencing of native DNA and RNA. Its platform provides rich genomic and epigenomic insights, distinguishing it from short-read sequencing competitors. The company has commercialized a range of devices from portable MinION to high-throughput PromethION, targeting research, applied science, and clinical diagnostics. With a strong IP portfolio and expanding customer base, Oxford Nanopore is positioned to capture growth in the genomics market, particularly in areas requiring structural variant detection and epigenetic analysis.

Upcoming Catalysts (preview)

• H2 2026FDA clearance for targeted sequencing panel in oncology40% success
• Q3 2026Launch of high-throughput PromethION 48 sequencer70% success
• Q4 2026Strategic partnership with a major diagnostics company for liquid biopsy50% success